IFN-gamma concentrations were assessed in subjects from your subset of population (N=44), at baseline (V1), after 10days of consumption of study products (V1+ 12 d) and at the end in the study (V3). subjects providing biological examples, we demonstrated that usage ofB. subtilisCU1 significantly increased fecal and salivary secretory IgA concentrations compared to the placebo. A post-hoc analysis about this subset demonstrated a decreased rate of recurrence PX-478 HCl of respiratory infections in the probiotc group compared to the placebo group. == Conclusion == Taken collectively, our research provides proof thatB. subtilisCU1 supplementation during the winter period may be a safe effective way to activate immune responses in seniors subjects. Keywords: Clinical trial, Elderly, Common infectious disease, Probiotics, Immunostimulation == History == Viral respiratory and Rabbit Polyclonal to PAK5/6 gastrointestinal infections are a predominant cause of morbidity and mortality in the seniors whose ageing immune system contributes significantly to poor final results [1]. Ageing is usually associated with a decline of innate and adaptive defense responses. Pertaining to innate dysfunction, it has been referred to that the function of organic killer cells, dendritic cells [2], macrophages [3] and neutrophils [4] decrease in the elderly. Moreover, age-dependent thymic involution contributes to the reduction of circulating naive To cells and the increase rate of recurrence of regulatory, memory and effector To cells [5, 6]. A dramatic reduction in W cell repertoire associated with a decreased systemic antibody response to vaccination has been observed in the elderly human population [7] showing that the W cell compartment is also affected by ageing [8, 9]. In addition , the production of secretory IgA (SIgA) at the mucosal surfaces decreases with era and can lead to an increased risk of infection [10, 11]. SIgA, the predominant immunoglobulin class in human external secretions, is actually a key element in the maintenance of stomach microbiota homeostasis and in the protection of gastrointestinal and respiratory tracts against pathogens [12]. Moreover, it has been also demonstrated that the age-dependent modifications in the composition in the gut microbiota PX-478 HCl also contribute to the defective local and systemic immune defenses in the seniors population [13, 14]. The development of strategies aimed at counterbalancing the defense frailty in the elderly is actually a major problem for 21stcentury medicine. Nutritional supplementation, including probiotics, in this population may help maintain defense function either by direct interaction with all the host defense mechanisms or indirectly by re-equilibrating the stomach microbiota [1517]. Probiotics PX-478 HCl have been defined as Live microorganisms which when administered in adequate quantities confer a health benefit on the number [18]. LactobacillusandBifidobacteriumare the most commonly used bacterial probiotics. Fermented milk or dairy products containingLactobacillushave shown effects on period or rate of recurrence of respiratory and gastrointestinal infections [1921] and reduced the risk of the normal cold in healthy seniors subjects [22]. Ma et PX-478 HCl al. [23] demonstrated significant styles in reducing infection occurrence and mortality due to pneumonia in institutionalized elderly subject matter treated with twoLactobacillus plantarumstrains. Some trials showed thatLactobacillusandBifidobacteriumprobiotics could increase influenza vaccination immune responses in the seniors [2427]. Endospore formers such asBacillusspecies are interesting because their particular spores resist the acid hurdle of the belly and are stable for long periods in commercial food products [28]. Bacilli, considered as stomach commensals, have already been used since probiotics pertaining to prophylaxis of human gastrointestinal disorders, to prevent recurrent respiratory infections or as an adjunct to antibiotic use [2934]. Probiotics have been suggested to protect against infectious diseases by several strain-dependant mechanisms [35, 36] including secretion of anti-pathogen substances, competitive exclusion of pathogens, maintenance of mucosal integrity and stimulation of systemic or mucosal defense responses.